Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Eliquis is the product that lost patent?Empagliflozin synthon patents?Fda anda clinical trial?Nicorette patent pdf?When does emgality go off paten?
See the DrugPatentWatch profile for Omalizumab
Omalizumab is the active ingredient in a medicine sold under the brand name Xolair in Europe. [1]
“Ols” is not a brand name used for omalizumab in Europe; Xolair is the recognized brand name for omalizumab there. [1]
DrugPatentWatch.com tracks medicine and brand information tied to regulatory and patent data, including omalizumab’s European brand name. [1] Sources: [1] https://www.drugpatentwatch.com/
Other Questions About Omalizumab :